AI assistant
Sending…
KORU Medical Systems, Inc. — Director's Dealing 2021
Dec 16, 2021
33778_dirs_2021-12-16_70d9e90e-3447-4d63-a958-c14ee2cf8fc5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPRO MED SYSTEMS INC (KRMD)
CIK: 0000704440
Period of Report: 2021-12-15
Reporting Person: Marques Manuel A (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-15 | Common Stock | M | 62500 | $0.50 | Acquired | 443080 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-15 | Options to Purchase Common Stock | $0.50 | M | 62500 | Disposed | 2022-10-10 | Common Stock (62500) | Direct |
Footnotes
F1: Represents the payment of the exercise price of stock options through the delivery of previously owned shares to the issuer.
F2: The price is equal to the Fair Market Value of the Common Stock, as defined in the stock option award agreements, and is used to determine the value of the shares delivered to the issuer in payment of the exercise price.
F3: Options vest in 15,625 increments quarterly.
More from KORU Medical Systems, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 6
Earnings Release
2026
May 6
Major Shareholding Notification
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 3
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 14